AMWatch

Media: Norwegian investors may lose nearly EUR 28m off investments in a UK biotech company

Salamander Invest has been the main financier of UK-based biotech company Fortuna Fix, which the High Court of Justice in London placed under administration in January. Currently, around NOK 300m (EUR 28m) is being invested in a firm, and more investments would be needed to keep the research going.
Stein Erik Hagen is one of Norway's richest persons. | Photo: Casper Dalhoff/KULTUR
Stein Erik Hagen is one of Norway's richest persons. | Photo: Casper Dalhoff/KULTUR
by REETA ILONA PAAKKINEN

Norwegian investors with Skagen’s founder Tor Dagfinn Veen and Stein Erik Hagen at the helm have lost close to NOK 300m (EUR 28m) in the British biotech company Fortuna Fix, writes Dagens Næringsliv.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
    • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms